GlassScriptPhysician profile
Jeffrey Allen Lamp
NPI 1134102650
$1,906.02
in general payments reported to CMS, 2019-2025
26 companies · $20.74 in 2025
The $20.74 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.31 · 2020: $1,000 · 2021: $543 · 2022: $72.33 · 2023: $148 · 2024: $48.50 · 2025: $20.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $209.31 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $201.08 | 2019-2021 | |
| Gilead Sciences, INC. | $196.64 | 2023-2024 | |
| Amgen INC. | $187.65 | 2020-2022 | |
| Novo Nordisk INC | $160.58 | 2019-2021 | |
| Glaxosmithkline, LLC. | $153.72 | 2019-2021 | |
| Abbvie INC. | $89.62 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $78.72 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $78.60 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.60 | 2020 | |
| Nestle Healthcare Nutrition INC. | $57.40 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $51.38 | 2019-2020 | |
| Abbott Laboratories | $50.21 | 2020-2021 | |
| Lilly USA, LLC | $43.12 | 2020-2022 | |
| Pfizer INC. | $41.45 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.29 | 2020 | |
| Astellas Pharma US INC | $31.03 | 2020 | |
| Currax Pharmaceuticals LLC | $29.15 | 2020 | |
| Janssen Pharmaceuticals, INC | $25.81 | 2021 | |
| Esperion Therapeutics, INC. | $23.63 | 2021 | |
| Exact Sciences Corporation | $20.74 | 2025 | The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $16.03 | 2021 | |
| Mylan Pharmaceuticals INC. | $15.00 | 2021 | |
| Merck Sharp & Dohme LLC | $14.61 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.37 | 2020 | |
| Paratek Pharmaceuticals, INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.